These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7850782)

  • 21. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
    Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenomedullin prevents apoptosis in prostate cancer cells.
    Abasolo I; Montuenga LM; Calvo A
    Regul Pept; 2006 Jan; 133(1-3):115-22. PubMed ID: 16297990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dihydrotestosterone (DHT) modulates the ability of NSAIDs to induce apoptosis of prostate cancer cells.
    Andrews P; Krygier S; Djakiew D
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):179-86. PubMed ID: 11935209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.
    Vilenchik M; Raffo AJ; Benimetskaya L; Shames D; Stein CA
    Cancer Res; 2002 Apr; 62(7):2175-83. PubMed ID: 11929841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS
    Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity.
    Lebedeva I; Rando R; Ojwang J; Cossum P; Stein CA
    Cancer Res; 2000 Nov; 60(21):6052-60. PubMed ID: 11085527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.
    Ling MT; Wang X; Ouyang XS; Xu K; Tsao SW; Wong YC
    Oncogene; 2003 Jul; 22(29):4498-508. PubMed ID: 12881706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen blocks apoptosis of hormone-dependent prostate cancer cells.
    Kimura K; Markowski M; Bowen C; Gelmann EP
    Cancer Res; 2001 Jul; 61(14):5611-8. PubMed ID: 11454715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen.
    Miyake H; Hara I; Gleave ME; Eto H
    Prostate; 2004 Dec; 61(4):318-23. PubMed ID: 15389725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
    Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
    Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
    Engedal N; Korkmaz CG; Saatcioglu F
    Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
    Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
    Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stage.
    Lin Y; Fukuchi J; Hiipakka RA; Kokontis JM; Xiang J
    Cell Res; 2007 Jun; 17(6):531-6. PubMed ID: 17404601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abrogation of heat-shock protein (HSP)70 expression induced cell growth inhibition and apoptosis in human androgen-independent prostate cancer cell line PC-3m.
    Zhao ZG; Ma QZ; Xu CX
    Asian J Androl; 2004 Dec; 6(4):319-24. PubMed ID: 15546023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen signaling and post-transcriptional downregulation of Bcl-2 in androgen-unresponsive prostate cancer.
    Rothermund CA; Gopalakrishnan VK; Vishwanatha JK
    Prostate Cancer Prostatic Dis; 2004; 7(2):158-64. PubMed ID: 15124003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells.
    Sun SY; Yue P; Lotan R
    Oncogene; 2000 Sep; 19(39):4513-22. PubMed ID: 11002424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
    Arnoldussen YJ; Lorenzo PI; Pretorius ME; Waehre H; Risberg B; Maelandsmo GM; Danielsen HE; Saatcioglu F
    Cancer Res; 2008 Nov; 68(22):9255-64. PubMed ID: 19010898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
    Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
    Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
    Dole M; Nuñez G; Merchant AK; Maybaum J; Rode CK; Bloch CA; Castle VP
    Cancer Res; 1994 Jun; 54(12):3253-9. PubMed ID: 8205548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.